Albertson Tina M. 4
4 · Lyell Immunopharma, Inc. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Albertson Tina M.
Chief Medical Officer
Transactions
- Award
Option (right to buy)
2023-02-24+700,000→ 700,000 totalExercise: $2.13Exp: 2033-02-23→ Common Stock (700,000 underlying)
Holdings
- 4,049
Common Stock
Footnotes (2)
- [F1]Includes 2,495 shares acquired on May 18, 2022 and 1,554 shares acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
- [F2]12.5% of the option shares shall vest on August 9, 2023, with the remaining option shares to vest in equal monthly installments over the following forty-two months.